Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Lack of Somatic Sequence Mutations In Protein Tyrosine Kinase Genes Other Than the JAK Kinase Family In High Risk B-Precursor Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) High-Risk (HR) ALL TARGET Project

Jinghui Zhang, Ph.D., Charles Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Richard Harvey, PhD, William L. Carroll, MD, I-Ming L. Chen, DVM, MS, Meenakshi Devidas, PhD, Eric Larsen, Michael Edmonson, Ph.D., Ken Buetow, Ph.D., Daniela S Gerhard, Ph.D., Mignon L. Loh, M.D., Gregory H. Reaman, MD, Mary V. Relling, PharmD, Malcolm A Smith, M.D., Ph.D., James R. Downing, MD, Cheryl L. Willman, MD, Stephen Hunger, MD

Blood (2010) 116 (21): 2752.

https://doi.org/10.1182/blood.V116.21.2752.2752

Published: 2010

Journal Articles

Identification of Novel LNK Mutations In Patients with Chronic Myeloproliferative Neoplasms and Related Disorders

Stephen T. Oh, M.D., Ph.D., Jacob M. Zahn, Ph.D., Carol D. Jones, B.A., Bing Zhang, M.D., M.S., Mignon L. Loh, M.D., Hagop Kantarjian, MD, Erin F. Simonds, B.S., Robert V. Bruggner, B.S., Parveen Abidi, Ph.D., Georges Natsoulis, Ph.D., John Bell, M.S., Jason Buenrostro, B.S., Garry P. Nolan, Ph.D., James L. Zehnder, M.D., Hanlee P. Ji, M.D., Jason Gotlib, M.D., M.S.

Blood (2010) 116 (21): 315.

https://doi.org/10.1182/blood.V116.21.315.315

Published: 2010

Journal Articles

Targeting mTOR Signaling Is An Effective Treatment Strategy for IKAROS and JAK Kinase Mutated Acute Lymphoblastic Leukemia

David T. Teachey, MD, TIffaney Vincent, Cheryl L. Willman, MD, Mignon L. Loh, M.D., Charles Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Stephen Hunger, MD, Stephan A. Grupp, MD, PhD

Blood (2010) 116 (21): 3251.

https://doi.org/10.1182/blood.V116.21.3251.3251

Published: 2010

Journal Articles

Targeting Survivin In Recalcitrant Acute Lymphoblastic Leukemia

Eugene Park, Enzi Jiang, MD, PhD, Yao-Te Hsieh, Lars Klemm, Cihangir Duy, Edward M. Conway, MD, PhD, FRCPC, MBA, Louis M. Pelus, PhD, John Crispino, PhD, Mignon L. Loh, M.D., Eun-Suk Kang, MD, PhD, Hong-Hoe Koo, MD, PhD, Allen Yang, MD, PhD, Nora Heisterkamp, PhD, Michael Kahn, PhD, Markus Muschen, MD, Yong-Mi Kim, MD, MPH

Blood (2010) 116 (21): 3263.

https://doi.org/10.1182/blood.V116.21.3263.3263

Published: 2010

Journal Articles

Overcoming Drug Resistance In Acute Lymphoblastic Leukemia by Inhibition of CBP/γ-Catenin

Enzi Jiang, MD, PhD, Eugene Park, Cu Nguyen, James Yoon, Yao-Te Hsieh, Mignon L. Loh, M.D., Markus Muschen, MD, Michael Kahn, Yong-mi Kim, MD, MPH

Blood (2010) 116 (21): 3264.

https://doi.org/10.1182/blood.V116.21.3264.3264

Published: 2010

Journal Articles

Early Response Characteristics and Blast Cytogenetic FEatures In 5,377 Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): A Children's Oncology Group (COG) Study

Kelly W. Maloney, Mignon L. Loh, M.D., Elizabeth Raetz, MD, Michael J. Borowitz, MD, PhD, Meenakshi Devidas, PhD, Alison M. Friedmann, MD, MSC, Leonard A. Mattano, MD, Brent Wood, MD, PhD, Naomi Winick, MD, Stephen Hunger, MD, William L. Carroll, MD

Blood (2010) 116 (21): 414.

https://doi.org/10.1182/blood.V116.21.414.414

Published: 2010

Journal Articles

Genome-Wide Analysis of Genetic Alterations In Hypodiploid Acute Lymphoblastic Leukemia Identifies a High Frequency of Mutations Targeting the IKAROS Gene Family and Ras Signaling

Linda Holmfeldt, PhD, Jinghui Zhang, Ph.D., Jing Ma, Ph.D., Meenakshi Devidas, PhD, Andrew J. Carroll, PhD, Nyla A. Heerema, Ph.D., Julie M. Gastier-Foster, PhD, Susana C. Raimondi, PhD, Mignon L. Loh, M.D., Stephen Hunger, MD, Charles Mullighan, MBBS, MD, FRACP, FRCPA, MSc

Blood (2010) 116 (21): 411.

https://doi.org/10.1182/blood.V116.21.411.411

Published: 2010

Journal Articles

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Stuart S. Winter, MD, Meenakshi Devidas, PhD, Brent Wood, MD, PhD, Michael J. Borowitz, MD, PhD, Mignon L. Loh, M.D., Barbara Asselin, MD, John Murphy, Elizabeth Raetz, MD, Naomi Winick, MD, Stephen Hunger, MD, William Carroll, MD, Kimberly Dunsmore, MD

Blood (2010) 116 (21): 865.

https://doi.org/10.1182/blood.V116.21.865.865

Published: 2010

Journal Articles

Adjuvant CD49d Blockade Eradicates Chemoresistant ALL

Yao-Te Hsieh, Eugene Park, Enzi Jiang, MD, PhD, Katrin Dauber, Doreen Chudziak, Paul Schaefer, Lars Klemm, Carlton Scharman, Eun-Suk Kang, MD, PhD, Hong-Hoe Koo, MD, PhD, Mignon L. Loh, M.D., Wolf Karsten Hofmann, MD, PhD, Nora Heisterkamp, Markus Muschen, MD, Hiroyuki Shimada, MD, Halvard Bonig, MD, MA, Yong-Mi Kim, MD, MPH

Blood (2010) 116 (21): 869.

https://doi.org/10.1182/blood.V116.21.869.869

Published: 2010

Journal Articles

Factors Influencing Survival after Relapse from Childhood ALL: A Children’s Oncology Group Study.

Kim Nguyen, Su-Chun Cheng, Ph.D, Elizabeth Raetz, M.D., Harland Sather, Ph.D, William L. Carroll, M.D., Naomi Winick, M.D., Stephen P. Hunger, M.D., Paul Gaynon, M.D., Mignon L. Loh, M.D.

Blood (2006) 108 (11): 1855.

https://doi.org/10.1182/blood.V108.11.1855.1855

Published: 2006

NARROW

Lack of Somatic Sequence Mutations In Protein Tyrosine Kinase Genes Other Than the JAK Kinase Family In High Risk B-Precursor Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) High-Risk (HR) ALL TARGET Project

Identification of Novel LNK Mutations In Patients with Chronic Myeloproliferative Neoplasms and Related Disorders

Targeting mTOR Signaling Is An Effective Treatment Strategy for IKAROS and JAK Kinase Mutated Acute Lymphoblastic Leukemia

Targeting Survivin In Recalcitrant Acute Lymphoblastic Leukemia

Overcoming Drug Resistance In Acute Lymphoblastic Leukemia by Inhibition of CBP/γ-Catenin

Early Response Characteristics and Blast Cytogenetic FEatures In 5,377 Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): A Children's Oncology Group (COG) Study

Genome-Wide Analysis of Genetic Alterations In Hypodiploid Acute Lymphoblastic Leukemia Identifies a High Frequency of Mutations Targeting the IKAROS Gene Family and Ras Signaling

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Adjuvant CD49d Blockade Eradicates Chemoresistant ALL

Factors Influencing Survival after Relapse from Childhood ALL: A Children’s Oncology Group Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only